Otilimab (GSK 3196165) is a human monoclonal antibody targeting the granulocyte-macrophage colony-stimulating factor (GM-CSF). This antibody effectively neutralizes GM-CSF by inhibiting its interaction with the cell surface receptor, thereby modulating the biological activities mediated by this cytokine. Otilimab is primarily researched for its potential therapeutic applications in conditions where GM-CSF plays a key role in pathogenesis.
Otilimab (GSK 3196165) is a human monoclonal antibody targeting the granulocyte-macrophage colony-stimulating factor (GM-CSF). This antibody effectively neutralizes GM-CSF by inhibiting its interaction with the cell surface receptor, thereby modulating the biological activities mediated by this cytokine. Otilimab is primarily researched for its potential therapeutic applications in conditions where GM-CSF plays a key role in pathogenesis.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
